Still Have Questions?
Find answers to the most common questions about NuuVim and our treatments.
Frequently Asked Questions
Once you complete your intake (a short medical questionnaire), a licensed medical professional will review your health information and, if approved, prescribe a medically guided weight loss solution customized to fit your needs. Your GLP-1 medication will be compounded to fit your unique health and lifestyle goals and will be shipped directly to you from licensed US-based pharmacies.
No, you don’t need a prior prescription. A licensed medical provider will review your health information and, if appropriate, provide a prescription as part of the consultation process.
While Semaglutide (GLP-1) itself is an active ingredient in FDA-approved drugs, compounded medications are prepared by pharmacies or physicians, and the FDA does not have an opportunity to review each compound before they reach patients. However, rest assured at NuuVim, your well-being and safety is our top priority which is why we partnered with compounding pharmacies that are state-regulated. These pharmacies adhere to strict regulatory board standards to ensure the safety and quality of our compounded GLP-1 medication prescriptions.
Compounded GLP-1 medications are prepared at compounding pharmacies based on a doctor's prescription. While compounded medications can offer valuable therapeutic options, patients should be aware that these formulations do not undergo the same clinical testing or regulatory scrutiny as FDA-approved drugs. If you have any questions or concerns about your prescribed compounded medication, we encourage you to speak directly with your healthcare provider or the dispensing pharmacy.
If you are eligible to participate in the NuuVim program, you will have the option to schedule a prescription fill with a video visit or, depending on the state, schedule a prescription fill without a video visit. During your first appointment, your provider will discuss your health goals, review your medical history, order any necessary lab tests, and may order a prescription medication if deemed appropriate. Your provider will collaborate with you to create a personalized health plan. Alongside lifestyle recommendations, your care plan may include a prescription for weight loss medication. Upon starting a weight loss medication, regular check-ins with your provider can be scheduled. The frequency of these visits can vary, but usually are once a month in the beginning. During these check-ins, the provider will evaluate your progress in weight loss, monitor your medication tolerance, arrange follow-up lab tests or prescription refills, and adjust your care plan as necessary.
While prescriptions for weight loss medication cannot be guaranteed for every patient, if you are 18 years of age or older and meet specific criteria such as weight and certain associated health conditions, your healthcare provider may consider you eligible for a prescription. Generally speaking, those who qualify are: individuals with overweight (BMI > 27) or obesity (BMI > 30) and those who are seeking maintenance therapy that have a BMI > 22 and if their current BMI < 27, have a history of obesity or overweight and have previously been on a GLP-1 within the past 12 months.
At this time, patients have to be at least 18 years old to participate in the program.
If your BMI drops below 27, it is possible that you may no longer require GLP-1 medications. In this situation, your healthcare provider will reassess your eligibility to determine if you can continue with the program. There are patients that may require maintenance therapy even if their BMI drops below 27 and your healthcare provider will determine if this option is right for you.
NuuVim only partners with physicians and licensed nurse practitioners who possess the qualifications to prescribe medications, order lab tests, and evaluate your symptoms and health objectives. They are well-equipped to develop a personalized care plan tailored to your specific needs.
If you meet any of the following criteria, you may not be eligible for a prescription of GLP-1 weight loss medication:
1. Currently pregnant, breastfeeding, or actively trying to become pregnant
2. End-stage kidney disease (on or about to be on dialysis)
3. End-stage liver disease (cirrhosis)
4. Active eating disorder or history of eating disorder (bulimia, anorexia, etc.)
5. Current suicidal thoughts and/or prior suicidal attempt
6. Cancer (active diagnosis or treatment)
7. Current or history of pancreatitis
8. History of organ transplant on anti-rejection medication
9. Severe gastrointestinal condition (gastroparesis, inflammatory bowel disease)
10. Personal or family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) type 2
Please note that these eligibility criteria are not exhaustive, and it is crucial to consult with your healthcare provider for a comprehensive assessment of your individual circumstances.
Yes. The active ingredients in our medications are FDA-approved and sourced from licensed US-based pharmacies. Our compounded medications meet strict safety and quality standards.
Your medical provider may recommend compounded semaglutide based on a medical review. Compounded drugs are not FDA approved and are not evaluated for safety, effectiveness, or quality standards. This document is a summary of product information and does NOT have all possible information and potential side effects of the product. This is not medical advice and does not substitute advice from your health care provider. Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. Your provider may recommend certain doses of compounded semaglutide based on your medical evaluation
Indications and Use:
Compounded semaglutide is an injectable prescription medicine that may help adults and adolescents with obesity and excess weight (overweight) - who may also have weight-related medical problems - lose weight and keep it off. It should be used with a reduced-calorie diet and increased physical activity. Compounded semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of 27 kg/m2 or higher. Compounded semaglutide should not be used with other semaglutide-containing products or any other GLP-1/GIP receptor agonist medicines. It is not known if compounded semaglutide is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if compounded semaglutide can be used in people who have had pancreatitis. It is not known if compounded semaglutide is safe and effective for use in children under 18 years of age.
At lower (micro) doses, compounded semaglutide may also be beneficial for patients who:
Have side effects at higher doses
Would like to reduce cardiovascular disease risk
Would like to reduce inflammation
Would like to improve gastrointestinal conditions such as inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS)Would like to protect against Alzheimer’s or Parkinson’s disease
Would like to reduce the use of alcohol or tobacco
Important Safety Information for Compounded Tirzepatide Injection
Warning: Risk of Thyroid C-Cell Tumors
In studies with mice and rats, semaglutide caused thyroid tumors, including thyroid cancer. It is not known if compounded semaglutide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. Do not use compounded semaglutide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Limitations of Use:
Compounded semaglutide should not be used in combination with other semaglutide-containing products or any other GLP-1/GIP receptor agonist medicines. The safety and efficacy of coadministration with other products for weight loss have not been established. Compounded semaglutide has not been studied in patients with a history of pancreatitis. Note: Compounded medications are not FDA approved and do not have indications for treatment as an FDA approved medication would.
Who should not use compounded semaglutide?
Do not use compounded semaglutide if:
You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).You have a known allergic reaction to compounded semaglutide.
How should compounded semaglutide be administered?
You can take compounded semaglutide with or without food. The pre-filled vial is self-administered with a needle and syringe as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your provider will guide you on a treatment regimen that may include an increase in dose every four weeks.You should not change your dosing regimen or stop taking compounded semaglutide as prescribed without discussing with your provider first.
What should I tell my provider before using compounded semaglutide?
Compounded semaglutide has certain drug interactions. It’s important to tell your provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.
Some medications to watch out for include:
Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL).Compounded semaglutide causes a delay in gastric emptying, so it has the potential to impact the absorption of medications that are taken by mouth at the same time. Your provider can guide you on how to schedule your medications.Other GLP-/GIP medications, including Wegovy® (semaglutide), Ozempic® (semaglutide), Saxenda® (liraglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide), Victoza® (liraglutide), Byetta® (exenatide), or Bydureon® (exenatide).If you’re using other products for weight loss, including dietary supplements.
It’s important to share your entire medical history with your provider.
In particular, tell your provider if you have a past history of:
Type 1 or type 2 diabetes
Thyroid cancer
Pancreatitis
Kidney disease
Diabetic retinopathy
Depression
Suicidal thoughts or behavior
Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.
If you are pregnant: Compounded semaglutide should not be used during pregnancy. Based on animal studies, there may be potential risks to an unborn baby from exposure to compounded semaglutide during pregnancy. There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby. If you are a female or male of reproductive potential: Discontinue compounded semaglutide at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time. If you are breastfeeding: Compounded semaglutide was found in the milk of lactating rats. Tell your provider if you are breastfeeding before you start compounded semaglutide. At this time, we do not recommend taking compounded semaglutide if you are breastfeeding or bottle-feeding with breastmilk. Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
What are the most serious side effects that I or a caregiver should monitor for when taking compounded semaglutide?
The most common side effects are typically mild and usually resolve after the first several weeks of treatment. These can include nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, abdominal distension, reflux, headache, fatigue, and dizziness. Swelling, redness, and itchiness at the injection site may occur. The FDA has issued its most serious warning (called a BOXED WARNING)that GLP-1s may be associated with a type of thyroid cancer called medullary thyroid carcinoma. So far, this side effect has primarily been seen in laboratory studies using rodents, so the risk to humans has not been determined.
SIDE EFFECTS:
Nausea, vomiting, stomach upset, diarrhea, tiredness, dizziness, or constipation may occur. Nausea usually lessens as you continue to use semaglutide. If any of these effects last or get worse, tell your provider or pharmacist promptly. Remember that this medication has been prescribed because your provider has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Vomiting/diarrhea that doesn’t stop may result in dehydration. Contact your provider promptly if you notice any symptoms of dehydration, such as unusual dry mouth/thirst or dizziness/ lightheadedness. Tell your provider right away if you have any serious side effects, including: signs of kidney problems (such as change in the amount of urine), vision changes (such as decreased/blurred vision), fast heartbeat, mental/mood changes (such as depression, thoughts of suicide), signs of low blood sugar (sudden sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness, tingling hands/feet). Get medical help right away if you have any very serious side effects, including: signs of pancreas or gallbladder disease (such as nausea/vomiting that doesn’t stop, severe stomach/abdominal pain). A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your provider or pharmacist. In the US - Call your provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch
WARNING:
This medication has been found to cause a certain type of thyroid tumor (thyroid C-cell tumors) in rats and mice. It is unknown if this medication can cause similar tumors in humans. Talk with your provider about the benefits and risks of treatment with this medication. This medication should not be used by people with a personal/family history of a certain type of cancer (medullary thyroid carcinoma) or by people with a certain inherited disease (Multiple Endocrine Neoplasia syndrome type 2 or MEN 2). While using this medication, tell your provider right away if you notice any signs or symptoms of thyroid tumors, including unusual growth or lump in the neck, difficulty swallowing, shortness of breath, or unusual/lasting hoarseness.
If you are experiencing a medical emergency, call 911 or seek immediate medical attention.
These serious side effects can occur with compounded semaglutide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
Thyroid C-Cell Tumors: In mice and rats, semaglutide caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether compounded semaglutide causes thyroid C-cell tumors in humans. There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza® and Saxenda®) after the drug was put on the market. Compounded semaglutide is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Inflammation of Pancreas (Acute Pancreatitis): Monitor for signs of acute pancreatitis, including severe abdominal pain that does not go away, sometimes radiating to the back, with or without vomiting.
Acute Gallbladder Disease: Compounded semaglutide may cause gallbladder problems, including gallstones. Some gallbladder problems require surgery. Tell your provider right away if you have pain in your upper stomach, yellowing of skin or eyes (jaundice), fever, or clay-colored stools.
Low Blood Sugar (Hypoglycemia): Compounded semaglutide may lower blood glucose. It can cause low blood sugar in patients with type 2 diabetes who also take another glucose control medication. Monitor your blood sugar and watch out for signs of too low blood sugar such as dizziness, blurred vision, mood changes, sweating, or fast heartbeat.
Acute Kidney Injury: In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink plenty of water to help reduce your chance of dehydration.
Serious Allergic Reactions: Stop using compounded semaglutide right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rashor itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy.
Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, tell your provider right away if you experience changes in vision.
Increase in Heart Rate: Tell your provider right away if you have a racing heartbeat while at rest.
Suicidal Behavior and Ideation: You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.
Never Share a Vial/Needle/Syringe: Sharing poses a risk of infection.
Current/Recent Prescriptions
If you have any current/recent prescriptions for either compounded or brand name weight loss medications, do not take both medications. You will be asked to provide evidence of the current/recent prescription including dose specifics. Taking two or more GLP-1/GIP medications at the same time increases the risk of potentially serious side effects. Notify your provider immediately if you have any current or previous prescriptions for compounded or brand name weight loss medications.
Medical History
Failure to fully disclose your medical history to your provider may result in serious side effects, including death.
Before using Compounded Semaglutide
Your healthcare provider will direct you to instructions on how to administer your GLP-1 therapy. Tell your healthcare provider if you are taking medicines to treat diabetes including insulin or sulfonylureas which could increase your risk of low blood sugar. Talk to your healthcare provider about low blood sugar levels and how to manage them. If you take birth control pills by mouth, talk to your healthcare provider before you use compounded semaglutide. Birth control pills may not work as well while using compounded semaglutide. Your healthcare provider may recommend another type of birth control for 4 weeks after you start compounded semaglutide and for 4 weeks after each increase in your dose of compounded semaglutide.
Review these questions with your healthcare provider:
Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis)or problems digesting food?
Do you take diabetes medicines, such as insulin or sulfonylureas?
Do you have a history of diabetic retinopathy?
Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Compounded semaglutide may harm your unborn baby. Tell your healthcare provider if you become pregnant while using compounded semaglutide. It is not known if compounded semaglutide passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using compounded semaglutide.
How to take:
Read the instructions that come with compounded semaglutide.
Use compounded semaglutide exactly as your healthcare provider says.
Compounded semaglutide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
Use compounded semaglutide 1 time each week on the same day every week.
Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
If you take too much compounded semaglutide, call your healthcare provider, seek medical advice promptly, or contact a Poison Center expert right away at 1-800-222-1222
Legal Disclaimers:
Compounded semaglutide is not approved by the FDA. The FDA does not evaluate compounded productsfor safety, effectiveness, or quality.Zepbound and Mounjaro is a registered trademark of Eli Lilly and Company. Ozempic, Wegovy, Saxenda, and Victoza are registered trademarks of Novo Nordisk A/S. Byetta and Bydureon are registeredtrademarks of Amylin Pharmaceuticals, Inc.
Your medical provider may recommend compounded tirzepatide based on a medical review. Compounded drugs are not FDA approved and are not evaluated for safety, effectiveness, or quality standards. This document is a summary of product information and does NOT have all possible information and potential side effects of the product. This is not medical advice and does not substitute advice from your health care provider. Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review. Your provider may recommend certain doses of compounded tirzepatide based on your medical evaluation.
Indications and Use: Compounded tirzepatide is an injectable prescription medicine that may help adults and adolescents with obesity and excess weight (overweight) - who may also have weight-related medical problems - lose weight and keep it off. It should be used with a reduced-calorie diet and increased physical activity. Compounded tirzepatide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of 27 kg/m2 or higher.
Compounded tirzepatide should not be used with other tirzepatide-containing products or any other GLP-1/GIP receptor agonist medicines. It is not known if compounded tirzepatide is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if compounded tirzepatide can be used in people who have had pancreatitis. It is not known if compounded tirzepatide is safe and effective for use in children under 18 years of age.
At lower (micro) doses, compounded tirzepatide may also be beneficial for patients who:
Have side effects at higher doses
Would like to reduce cardiovascular disease risk
Would like to reduce inflammation
Would like to improve gastrointestinal conditions such as inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS)Would like to protect against Alzheimer’s or Parkinson’s disease
Would like to reduce the use of alcohol or tobacco
Important Safety Information for Compounded Tirzepatide Injection
Warning: Risk of Thyroid C-Cell Tumors
In studies with mice and rats, tirzepatide caused thyroid tumors, including thyroid cancer. It is not known if compounded tirzepatide will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. Do not use compounded tirzepatide if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Limitations of Use:
Compounded tirzepatide should not be used in combination with other tirzepatide-containing products or any other GLP-1/GIP receptor agonist medicines. The safety and efficacy of coadministration with other products for weight loss have not been established.Compounded tirzepatide has not been studied in patients with a history of pancreatitis. Note: Compounded medications are not FDA approved and do not have indications for treatment as an FDA approved medication would.
Who should not use compounded tirzepatide?
Do not use compounded tirzepatide if:
You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).You have a known allergic reaction to compounded tirzepatide.
How should compounded tirzepatide be administered?
You can take compounded tirzepatide with or without food. The pre-filled vial is self-administered with a needle and syringe as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week. Your provider will guide you on a treatment regimen that may include an increase in dose every four weeks. You should not change your dosing regimen or stop taking compounded tirzepatide as prescribed without discussing with your provider first.
What should I tell my provider before using compounded tirzepatide?
Compounded tirzepatide has certain drug interactions. It’s important to tell your provider all of the medications you are currently taking, including prescription, over-the-counter medications, vitamins, and herbal and dietary supplements.
Some medications to watch out for include:
Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL).Compounded tirzepatide causes a delay in gastric emptying, so it has the potential to impact the absorption of medications that are taken by mouth at the same time. Your provider can guide you on how to schedule your medications.
Other GLP-/GIP medications, including Wegovy® (tirzepatide), Ozempic® (tirzepatide), Saxenda® (liraglutide), Zepbound® (tirzepatide), Mounjaro® (tirzepatide), Victoza® (liraglutide), Byetta® (exenatide), or Bydureon® (exenatide).If you’re using other products for weight loss, including dietary supplements.
It’s important to share your entire medical history with your provider.
In particular, tell your provider if you have a past history of:
Type 1 or type 2 diabetes
Thyroid cancer
Pancreatitis
Kidney disease
Diabetic retinopathy
Depression
Suicidal thoughts or behavior
Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding.
If you are pregnant: Compounded tirzepatide should not be used during pregnancy. Based on animal studies, there may be potential risks to an unborn baby from exposure to compounded tirzepatide during pregnancy. There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby. If you are a female or male of reproductive potential: Discontinue compounded tirzepatide at least 2 months before a planned pregnancy since the drug can stay in the bloodstream for a long time. If you are breastfeeding: Compounded tirzepatide was found in the milk of lactating rats. Tell your provider if you are breastfeeding before you start compounded tirzepatide. At this time, we do not recommend taking compounded tirzepatide if you are breastfeeding or bottle-feeding with breastmilk. Withholding or providing inaccurate information about your health and medical history in order to obtain treatment may result in harm, including, in some cases, death.
What are the most serious side effects that I or a caregiver should monitor for when taking compounded tirzepatide?
The most common side effects are typically mild and usually resolve after the first several weeks of treatment. These can include nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, abdominal distension, reflux, headache, fatigue, and dizziness. Swelling, redness, and itchiness at the injection site may occur. The FDA has issued its most serious warning (called a BOXED WARNING)that GLP-1s may be associated with a type of thyroid cancer called medullary thyroid carcinoma. So far, this side effect has primarily been seen in laboratory studies using rodents, so the risk to humans has not been determined.
SIDE EFFECTS:
Nausea, vomiting, stomach upset, diarrhea, tiredness, dizziness, or constipation may occur. Nausea usually lessens as you continue to use tirzepatide. If any of these effects last or get worse, tell your provider or pharmacist promptly. Remember that this medication has been prescribed because your provider has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Vomiting/diarrhea that doesn’t stop may result in dehydration. Contact your provider promptly if you notice any symptoms of dehydration, such as unusual dry mouth/thirst or dizziness/ lightheadedness. Tell your provider right away if you have any serious side effects, including: signs of kidney problems (such as change in the amount of urine), vision changes (such as decreased/blurred vision), fast heartbeat, mental/mood changes (such as depression, thoughts of suicide), signs of low blood sugar (sudden sweating, shaking, fast heartbeat, hunger, blurred vision, dizziness, tingling hands/feet).
Get medical help right away if you have any very serious side effects, including: signs of pancreas or gallbladder disease (such as nausea/vomiting that doesn’t stop, severe stomach/abdominal pain). A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.This is not a complete list of possible side effects. If you notice other effects not listed above, contact your provider or pharmacist.
In the US - Call your provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch
WARNING:
This medication has been found to cause a certain type of thyroid tumor (thyroid C-cell tumors) in rats and mice. It is unknown if this medication can cause similar tumors in humans. Talk with your provider about the benefits and risks of treatment with this medication. This medication should not be used bypeople with a personal/family history of a certain type of cancer (medullary thyroid carcinoma) or by people with a certain inherited disease (Multiple Endocrine Neoplasia syndrome type 2 or MEN 2). While using this medication, tell your provider right away if you notice any signs or symptoms of thyroid tumors, including unusual growth or lump in the neck, difficulty swallowing, shortness of breath, or unusual/lasting hoarseness
If you are experiencing a medical emergency, call 911 or seek immediate medical attention. These serious side effects can occur with compounded semaglutide. You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes.
Thyroid C-Cell Tumors: In mice and rats, tirzepatide caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether compounded tirzepatide causes thyroid C-cell tumors in humans. There were cases of MTC reported in patients who took liraglutide (the active ingredient in Victoza® and Saxenda®) after the drug was put on the market. Compounded tirzepatide is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Inflammation of Pancreas (Acute Pancreatitis): Monitor for signs of acute pancreatitis, including severe abdominal pain that does not go away, sometimes radiating to the back, with or without vomiting.
Acute Gallbladder Disease: Compounded tirzepatide may cause gallbladder problems, including gallstones. Some gallbladder problems require surgery. Tell your provider right away if you have pain in your upper stomach, yellowing of skin or eyes (jaundice), fever, or clay-colored stools.
Low Blood Sugar (Hypoglycemia): Compounded tirzepatide may lower blood glucose. It can cause low blood sugar in patients with type 2 diabetes who also take another glucose control medication. Monitor your blood sugar and watch out for signs of too low blood sugar such as dizziness, blurred vision, mood changes, sweating, or fast heartbeat.
Acute Kidney Injury: In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration) which may cause kidney problems to get worse. It is important for you to drink plenty of water to help reduce your chance of dehydration.
Serious Allergic Reactions: Stop using compounded tirzepatide right away if you experience symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, severe rash or itching, very rapid heartbeat, problems breathing or swallowing, or fainting or feeling dizzy.
Diabetic Retinopathy Complications in Patients with Type 2 Diabetes: If you have type 2 diabetes, tell your provider right away if you experience changes in vision.
Increase in Heart Rate: Tell your provider right away if you have a racing heartbeat while at rest.
Suicidal Behavior and Ideation: You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you.
Never Share a Vial/Needle/Syringe: Sharing poses a risk of infection.
Current/Recent Prescriptions
If you have any current/recent prescriptions for either compounded or brand name weight loss medications, do not take both medications. You will be asked to provide evidence of the current/recent prescription including dose specifics. Taking two or more GLP-1/GIP medications at the same time increases the risk of potentially serious side effects. Notify your provider immediately if you have any current or previous prescriptions for compounded or brand name weight loss medications.
Medical History
Failure to fully disclose your medical history to your provider may result in serious side effects, including death. Before using Compounded Tirzepatide Your healthcare provider will direct you to instructions on how to administer your GLP-1 therapy. Tell your healthcare provider if you are taking medicines to treat diabetes including insulin or sulfonylureas which could increase your risk of low blood sugar. Talk to your healthcare provider about low blood sugar levels and how to manage them. If you take birth control pills by mouth, talk to your healthcare provider before you use compounded tirzepatide. Birth control pills may not work as well while using compounded tirzepatide. Your healthcare provider may recommend another type of birth control for 4 weeks after you start compounded tirzepatide and for 4 weeks after each increase in your dose of compounded tirzepatide.
Review these questions with your healthcare provider:
Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis)or problems digesting food?
Do you take diabetes medicines, such as insulin or sulfonylureas?
Do you have a history of diabetic retinopathy?
Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?
Are you pregnant, plan to become pregnant, breastfeeding, or plan to breastfeed? Compounded tirzepatide may harm your unborn baby. Tell your healthcare provider if you become pregnant while using compounded tirzepatide. It is not known if compounded tirzepatide passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using compounded tirzepatide.
How to take:
Read the instructions that come with compounded tirzepatide.
Use compounded tirzepatide exactly as your healthcare provider says.
Compounded tirzepatide is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
Use compounded tirzepatide 1 time each week on the same day every week.
Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
If you take too much compounded tirzepatide, call your healthcare provider, seek medical advice promptly, or contact a Poison Center expert right away at 1-800-222-1222.
Depending on your specific situation, your maintenance dose could be lower than 15 mg once a week.
Follow the dosing instructions from your provider, as they may personalize your plan for your individual needs.
Oral forms of compounded tirzepatide are typically dosed between 3-6 mg daily.
For micro-dosing purposes, compounded tirzepatide dosing starts at 1.25 mg once or twice weekly. Orally micro-dosed compounded tirzepatide is typically at 1.5 mg daily
Legal Disclaimers:
Compounded tirzepatide is not approved by the FDA. The FDA does not evaluate compounded products for safety, effectiveness, or quality. Zepbound and Mounjaro is a registered trademark of Eli Lilly and Company. Ozempic, Wegovy, Saxenda, and Victoza are registered trademarks of Novo Nordisk A/S. Byetta and Bydureon are registered trademarks of Amylin Pharmaceuticals, Inc.
Our program begins with a quick online consultation. A licensed medical professional reviews your health information and, if approved, prescribes FDA-approved weight loss medications. Your treatment plan is customized to fit your needs, and medications are shipped directly to you from licensed US-based pharmacies.
Yes. The active ingredients in our medications are FDA-approved and sourced from licensed US-based pharmacies. Our compounded medications meet strict safety and quality standards.
No, you don’t need a prior prescription. Our licensed medical team will review your health information and, if appropriate, provide a prescription as part of the consultation process.
As with any medication, there may be side effects. Common ones include nausea, mild stomach discomfort, and appetite changes. Side effects are typically temporary and lessen over time. Our medical team will guide you through managing them.
Your plan is tailored based on your health history, weight loss goals, and lifestyle. Our medical experts ensure you receive the right dosage and ongoing support for the best results.
Our pricing varies depending on the medication and treatment plan. We offer flexible plans to fit different needs, with transparent pricing and no hidden fees. Visit our pricing page for details.
At this time, we do not accept insurance. However, we strive to keep our pricing competitive and offer affordable options compared to traditional weight loss treatments.
Once your prescription is approved, it is sent to a licensed US-based pharmacy, where it is compounded and shipped directly to your doorstep. You don’t need to visit a pharmacy—everything is handled online for your convenience.
Our program begins with a quick online consultation. A licensed medical professional reviews your health information and, if approved, prescribes FDA-approved weight loss medications. Your treatment plan is customized to fit your needs, and medications are shipped directly to you from licensed US-based pharmacies.
Yes. The active ingredients in our medications are FDA-approved and sourced from licensed US-based pharmacies. Our compounded medications meet strict safety and quality standards.
Our program begins with a quick online consultation. A licensed medical professional reviews your health information and, if approved, prescribes FDA-approved weight loss medications. Your treatment plan is customized to fit your needs, and medications are shipped directly to you from licensed US-based pharmacies.
Yes. The active ingredients in our medications are FDA-approved and sourced from licensed US-based pharmacies. Our compounded medications meet strict safety and quality standards.
No, you don’t need a prior prescription. Our licensed medical team will review your health information and, if appropriate, provide a prescription as part of the consultation process.
As with any medication, there may be side effects. Common ones include nausea, mild stomach discomfort, and appetite changes. Side effects are typically temporary and lessen over time. Our medical team will guide you through managing them.
Your plan is tailored based on your health history, weight loss goals, and lifestyle. Our medical experts ensure you receive the right dosage and ongoing support for the best results.
Our pricing varies depending on the medication and treatment plan. We offer flexible plans to fit different needs, with transparent pricing and no hidden fees. Visit our pricing page for details.
At this time, we do not accept insurance. However, we strive to keep our pricing competitive and offer affordable options compared to traditional weight loss treatments.
Once your prescription is approved, it is sent to a licensed US-based pharmacy, where it is compounded and shipped directly to your doorstep. You don’t need to visit a pharmacy—everything is handled online for your convenience.
Our program begins with a quick online consultation. A licensed medical professional reviews your health information and, if approved, prescribes FDA-approved weight loss medications. Your treatment plan is customized to fit your needs, and medications are shipped directly to you from licensed US-based pharmacies.
Yes. The active ingredients in our medications are FDA-approved and sourced from licensed US-based pharmacies. Our compounded medications meet strict safety and quality standards.
Ready to Start Your Journey?
Safe and effective weight loss is just a click away
